Divi's Laboratories Limited Divi's Laboratories Limited

Divi's Laboratories Limited

DIVISLAB

Classement en actions #910
Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India,... Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India, operates globally in the production and distribution of generic active pharmaceutical ingredients (APIs), intermediate chemicals, and nutraceuticals. The company's market footprint encompasses India, the United States, Asia, Europe, and other international regions. In addition to its core product lines, Divi's offers bespoke synthesis services for APIs and intermediates. It also provides a diverse range of carotenoids and markets various vitamins, catering to the nutritional, pharmaceutical, food and beverage, and animal feed industries. The firm was formerly known as Divi's Research Center before rebranding to Divi's Laboratories Limited in 1994.
Prix de l'action
$100.28
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$26.62B
Changement (1 jour)
-0.41%
Changement (1 an)
33.45%
Pays
IN
Échange Divi's Laboratories Limited (DIVISLAB)

Catégorie

Healthcare
Bénéfices pour Divi's Laboratories Limited (DIVISLAB)
Bénéfices en Jun 2026 TTM : $423.23M
Selon les derniers rapports financiers de Divi's Laboratories Limited, les bénéfices actuels de l'entreprise sont de $423.23M. En 2024, l'entreprise a réalisé un bénéfice de $259.40M, une diminution par rapport à celui de 2023 qui était de $288.22M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Divi's Laboratories Limited de 2005 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $423.23M 24.13%
2025 $340.95M 31.43%
2024 $259.40M -10.00%
2023 $288.22M -40.60%
2022 $485.25M 33.24%
2021 $364.19M 50.80%
2020 $241.52M -9.59%
2019 $267.15M 41.26%
2018 $189.12M -12.11%
2017 $215.17M 2.34%
2016 $210.24M 22.37%
2015 $171.81M 3.93%
2014 $165.32M 14.98%
2013 $143.78M 7.12%
2012 $134.23M 26.63%
2011 $106.00M 23.55%
2010 $85.80M -2.83%
2009 $88.29M -6.41%
2008 $94.34M 86.53%
2007 $50.58M -313.15%
2006 $-23.73M -201.27%
2005 $23.43M 0.00%
Bénéfices des entreprises similaires ou concurrentes